BRPI0902039B8 - composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais - Google Patents
composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animaisInfo
- Publication number
- BRPI0902039B8 BRPI0902039B8 BRPI0902039A BRPI0902039A BRPI0902039B8 BR PI0902039 B8 BRPI0902039 B8 BR PI0902039B8 BR PI0902039 A BRPI0902039 A BR PI0902039A BR PI0902039 A BRPI0902039 A BR PI0902039A BR PI0902039 B8 BRPI0902039 B8 BR PI0902039B8
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- prophylaxis
- humans
- animals
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais. a presente invenção refere-se a composições farmacêuticas que compreendem fenolatos metálicos polifuncionais que apresentam aplicações biológicas como adjuvantes antitumorais, citoprotetores, agentes antimetastáticos e agentes antimutagênicos quando associados a quimioterápicos. a presente invenção refere-se ainda ao uso fenolatos metálicos polifuncionais na preparação de medicamentos para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0902039A BRPI0902039B8 (pt) | 2009-06-09 | 2009-06-09 | composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais |
JP2012514299A JP5802658B2 (ja) | 2009-06-09 | 2009-11-11 | 人および動物の腫瘍性疾患の治療、抑制あるいは予防用医薬組成物、および医薬組成物の使用 |
EP09845661.9A EP2441452B1 (en) | 2009-06-09 | 2009-11-11 | Pharmaceutical composition and use of the pharmaceutical composition for the treatment, prophylaxis or prevention of neoplastic diseases in humans and animals |
US13/377,194 US9381169B2 (en) | 2009-06-09 | 2009-11-11 | Pharmaceutical composition and use of the pharmaceutical composition for the treatment, prophylaxis or prevention of neoplastic diseases in humans and animals |
PCT/BR2009/000375 WO2010142007A1 (pt) | 2009-06-09 | 2009-11-11 | Composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0902039A BRPI0902039B8 (pt) | 2009-06-09 | 2009-06-09 | composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais |
Publications (4)
Publication Number | Publication Date |
---|---|
BRPI0902039A2 BRPI0902039A2 (pt) | 2011-02-22 |
BRPI0902039A8 BRPI0902039A8 (pt) | 2017-10-03 |
BRPI0902039B1 BRPI0902039B1 (pt) | 2021-03-30 |
BRPI0902039B8 true BRPI0902039B8 (pt) | 2021-05-25 |
Family
ID=43308327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0902039A BRPI0902039B8 (pt) | 2009-06-09 | 2009-06-09 | composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais |
Country Status (5)
Country | Link |
---|---|
US (1) | US9381169B2 (pt) |
EP (1) | EP2441452B1 (pt) |
JP (1) | JP5802658B2 (pt) |
BR (1) | BRPI0902039B8 (pt) |
WO (1) | WO2010142007A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115414465A (zh) * | 2022-10-17 | 2022-12-02 | 苏州明人医药生物科技有限公司 | Jwa多肽在制备抗肿瘤药协同增效剂方面的应用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4352883A (en) | 1979-03-28 | 1982-10-05 | Damon Corporation | Encapsulation of biological material |
US4353888A (en) | 1980-12-23 | 1982-10-12 | Sefton Michael V | Encapsulation of live animal cells |
US4883666A (en) | 1987-04-29 | 1989-11-28 | Massachusetts Institute Of Technology | Controlled drug delivery system for treatment of neural disorders |
US5283187A (en) | 1987-11-17 | 1994-02-01 | Brown University Research Foundation | Cell culture-containing tubular capsule produced by co-extrusion |
US5158881A (en) | 1987-11-17 | 1992-10-27 | Brown University Research Foundation | Method and system for encapsulating cells in a tubular extrudate in separate cell compartments |
DE3829766A1 (de) | 1988-09-01 | 1990-03-22 | Akzo Gmbh | Verfahren zur herstellung von membranen |
DE3829752A1 (de) | 1988-09-01 | 1990-03-22 | Akzo Gmbh | Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration |
US5082670A (en) | 1988-12-15 | 1992-01-21 | The Regents Of The University Of California | Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system |
US5084350A (en) | 1990-02-16 | 1992-01-28 | The Royal Institution For The Advance Of Learning (Mcgill University) | Method for encapsulating biologically active material including cells |
US5618531A (en) | 1990-10-19 | 1997-04-08 | New York University | Method for increasing the viability of cells which are administered to the brain or spinal cord |
ATE156344T1 (de) | 1991-04-25 | 1997-08-15 | Univ Brown Res Found | Implantierbare, biokompatible immunisolator- trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte |
US5854217A (en) | 1992-09-28 | 1998-12-29 | Bearsden Bio, Inc. | Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
EP1179350A3 (en) | 1993-08-12 | 2003-01-02 | Cytotherapeutics, Inc. | Encapsulated cell system for implantation into the human CNS |
CA2393440A1 (en) * | 1999-12-03 | 2001-06-07 | Emory University | Curcumin analogs with anti-tumor and anti-angiogenic properties |
US7355081B2 (en) | 2002-04-17 | 2008-04-08 | The University Of North Carolina At Chapel Hill | Curcumin analogues and uses thereof |
US20060258752A1 (en) | 2004-02-12 | 2006-11-16 | Vander Jagt David L | Method and compounds for cancer treatment utilizing NFkB as a direct or ultimate target for small molecule inhibitors |
US8841326B2 (en) * | 2004-02-12 | 2014-09-23 | Stc.Unm | Therapeutic curcumin derivatives |
WO2007007207A2 (en) * | 2005-04-13 | 2007-01-18 | Khairia Youssef | Pharmaceutical compositions of 3, 5 -bis (arylidene) -4 -piperidones and analogues there of for modulating cell proliferation |
WO2007075772A2 (en) * | 2005-12-20 | 2007-07-05 | President And Fellows Of Harvard College | Compounds, screens, and methods of treatment |
BRPI0602640B8 (pt) * | 2006-07-06 | 2021-05-25 | Anhanguera Educacional Ltda | métodos de obtenção de penta-1,4-dien-3-onas e de cicloexanonas substituídas e derivados com propriedades antitumorais e antiparasitárias, processo para preparar 1,5-bis-(aril)-penta-1,4-dien-3-onas alquiladas e aciladas, processo para preparar 4-nitro-3,5-diaril-cicloexanonas substituídas, processo para preparar 2,6-dibenzilideno-4-nitro-3,5-diaril-cicloexanonas substituídas, processo para preparar uma mistura formada por quantidades determinadas dos compostos (1,5-bis(4-hidróxi-3-metóxi-fenil)penta-1,4-dien-3-ona) e (1,5-bis(3-metóxi-4-acetóxi-fenil)penta-1,4-dien-3-ona), compostos e seus usos, composição farmacêutica, método terapêutico para tratamento dos cânceres e composição sinérgica |
-
2009
- 2009-06-09 BR BRPI0902039A patent/BRPI0902039B8/pt active IP Right Grant
- 2009-11-11 WO PCT/BR2009/000375 patent/WO2010142007A1/pt active Application Filing
- 2009-11-11 US US13/377,194 patent/US9381169B2/en active Active
- 2009-11-11 EP EP09845661.9A patent/EP2441452B1/en not_active Not-in-force
- 2009-11-11 JP JP2012514299A patent/JP5802658B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US9381169B2 (en) | 2016-07-05 |
EP2441452B1 (en) | 2018-12-26 |
EP2441452A1 (en) | 2012-04-18 |
JP2012529439A (ja) | 2012-11-22 |
BRPI0902039A2 (pt) | 2011-02-22 |
EP2441452A4 (en) | 2013-01-02 |
WO2010142007A1 (pt) | 2010-12-16 |
JP5802658B2 (ja) | 2015-10-28 |
BRPI0902039B1 (pt) | 2021-03-30 |
WO2010142007A8 (pt) | 2012-01-26 |
BRPI0902039A8 (pt) | 2017-10-03 |
US20120082703A1 (en) | 2012-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015012055A2 (pt) | misturas fungicidas ternárias | |
BR112015000150A2 (pt) | composições farmacêuticas dissuasoras de abuso de liberação controlada | |
PA8772101A1 (es) | Imidazol-triazolopirimidinas sustituidas | |
BR112012010270A2 (pt) | mentisulfonilmetano (msm) para tratamento de micro-organismos resistentes a fármaco | |
GT200900095A (es) | Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas. | |
IN2014DN06501A (pt) | ||
DOP2012000299A (es) | 5-fluoro-1h-pirazolopiridinas sustituidas y su uso | |
UA115558C2 (uk) | Алкілпіримідинові похідні для лікування вірусних інфекцій та подальших захворювань | |
IN2012DN00624A (pt) | ||
CR20130264A (es) | Compuestos pirimidinona para uso en el tratamiento de enfermedades o condiciones mediadas por lp-pla2 | |
MX2011009847A (es) | Agentes antihelminticos y su uso. | |
BR112012005044A2 (pt) | composições que compreendem tramadol e celecoxib no tratamento de dor. | |
MX2019003249A (es) | Diagnostico, prevencion y tratamiento de enfermedades de la articulacion. | |
UY30762A1 (es) | Sal fumarato de (alfa s, beta r)-6-bromo-alfa-[2(dimetilamino) etil]-2-metoxi-alfa-1-naftalenil-beta-fenil-3-quinolinaetanol | |
UY35276A (es) | Nuevos compuestos que inhiben la actividad de Lp-PLA2 | |
MX347105B (es) | Composiciones farmaceuticas que comprenden hidromorfona y naloxona. | |
UY31133A1 (es) | "oxazolidinonas sustituidas y su uso" | |
MX2016000294A (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. | |
AR053775A1 (es) | Nonadepsipeptidos acilados ii | |
TW200745042A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
BR112015012057A2 (pt) | misturas binárias fungicidas | |
UY33723A (es) | ?COMPUESTOS Y SU USO PARA TRATAMIENTO DE ENFERMEDADES RELACIONADAS CON Aß?. | |
UA113151C2 (xx) | Застосування композиції, що містить антимікробний поліпептид, у виробництві лікарського засобу | |
IN2012DN03096A (pt) | ||
MX2018000092A (es) | Nuevo lipolantipeptido biciclico, preparacion y uso como agente antimicrobiano. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B04C | Request for examination: application reinstated [chapter 4.3 patent gazette] | ||
B25C | Requirement related to requested transfer of rights |
Owner name: UNIVERSIDADE BANDEIRANTE DE SAO PAULO-ACADEMIA PAU |
|
B25D | Requested change of name of applicant approved |
Owner name: FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAU |
|
B25A | Requested transfer of rights approved |
Owner name: FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAU |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/03/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/06/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |